Bell Investment Advisors »

Protagonist Therapeutics shares owned by Bell Investment Advisors

Quarter-by-quarter ownership of Protagonist Therapeutics (PTGX) shares owned by Bell Investment Advisors from 13F filings

Historical chart of Bell Investment Advisors investment in Protagonist Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protagonist Therapeutics held by Bell Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protagonist Therapeutics by Bell Investment Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $492 17 28.94

More positions owned by Bell Investment Advisors

Goldman Sachs Etf Tr Acces Treasury (GBIL)
Schwab Strategic Tr Schwab Fdt Us Lg (FNDX)
Flexshares Tr Iboxx 3r Targt (TDTT)
Vanguard Scottsdale Fds Mtg-bkd Secs Etf (VMBS)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Schwab Strategic Tr Schwb Fdt Int Lg (FNDF)
Schwab Strategic Tr Schwab Fdt Us Sc (FNDA)
Ishares Tr Msci Usa Mmentm (MTUM)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Vanguard Index Fds Value Etf (VTV)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Invesco Exch Traded Fd Tr Ii S&p500 Low Vol (SPLV)
Schwab Strategic Tr Intl Eqty Etf (SCHF)
Ishares Tr Core S&p Scp Etf (IJR)
Schwab Strategic Tr Us Dividend Eq (SCHD)

View all positions for Bell Investment Advisors

Top funds holding Protagonist Therapeutics

Farallon Capital Management
BlackRock
BVF
Vanguard Group
Johnson & Johnson
Adage Capital Partners GP
Morgan Stanley
Cowen And Company
Geode Capital Management
Point72 Asset Management
Leucadia National Corporation
Kynam Capital Management
Perceptive Advisors
Marshall Wace
Fairmount Funds Management

View all funds holding Protagonist Therapeutics